The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Expressions of EGFR, HER2, and HER3 and their correlations with clinical characteristics in oropharyngeal squamous cell carcinoma (OPSCC).
Nabil F. Saba
Research Funding - Merrimack Pharmaceuticals
Guoquing Qian
No relevant relationships to disclose
Jiang Ning
No relevant relationships to disclose
Sungjin Kim
No relevant relationships to disclose
Zhengjia Chen
No relevant relationships to disclose
Gabriela Garcia
Employment or Leadership Position - Merrimack Pharmaceuticals
Stock Ownership - Merrimack Pharmaceuticals
Gavin MacBeath
Employment or Leadership Position - Merrimack Pharmaceuticals
Stock Ownership - Merrimack Pharmaceuticals
Dong Moon Shin
No relevant relationships to disclose
Fadlo Raja Khuri
No relevant relationships to disclose
Zhuo Georgia Chen
Research Funding - Merrimack Pharmaceuticals